Director/PDMR Shareholding - Purchase of Shares

Trifast

24/03/2025 12:12

RNS Number : 9055B

Trifast PLC

24 March 2025

 

 

Monday, 24 March 2025

 

 

 

 

Trifast plc

(the "Company")

 

Director/PDMR shareholding

 

The Company confirms that certain investment vehicles connected with Nicholas Mills, a Director of the Company, purchased 152,500 Ordinary Shares at a price of 67.1946p on 21 March 2025.

 

Following this purchase, Nicholas Mills and the investment vehicles connected with him are interested in 21,337,500 Ordinary Shares, representing 15.676% of the Company's issued share capital.

 

 

Enquiries:

Trifast plc

Christopher Morgan

Company Secretary

Tel: +44 (0) 1825 769696

www.trifast.com

 

 

The notification below is made in accordance with the requirements of the EU Market Abuse Regulation.

 

1.
Details of the person discharging managerial responsibilities / person closely associated
a.
Name
Rockwood Strategic Plc, PCA to Nicholas Mills
2.
Reason for the notification
a.
Position/status
PCA to PDMR
b.
Initial notification/Amendment
Initial notification
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.
Name
Trifast plc
b.
LEI
213800WFIVE6RWK3CR22
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.
Description of the financial instrument, type of instrument Identification code
Ordinary shares of 5 pence each
GB0008883927
b.
Nature of the transaction
Share purchase
c.
Price(s) and volume(s)
Price(s)
Volume(s)
67.1946p
152,500
d.
Aggregated information
· Aggregated volume
· Price
152,500
67.1946p
e.
Date of the transaction
21 March 2025
f.
Place of the transaction
London Stock Exchange, Main Market (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
DSHPPUGGWUPAGPC